The Department of Health and Human Services today
Novel Coronavirus (COVID-19) News
Below are links to AHA Today stories on novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.
Latest
An experimental mRNA vaccine for the COVID-19 virus generated a strong immune response in older adults in a phase 1 clinical trial, who generally tolerated it well, the National Institutes of Health reports.
The National Institutes of Health has awarded nearly $234 million to improve COVID-19 testing for underserved and vulnerable populations, such as African Americans, American Indians/Alaskan Natives, Latinos/Latinas, Native Hawaiians, older adults, pregnant women and those who are homeless or incarcerated.
The Federal Communications Commission’s Wireline Competition Bureau has extended to Dec. 31 the deadline for recipients of COVID-19 Telehealth Program funding to purchase and implement eligible telehealth devices and services to address the COVID-19 pandemic.
The Trump administration began distributing 150 million rapid point-of-care tests for the COVID-19 virus that it purchased in August, which will go to states and territories (100 million), nursing homes (18 million), assisted living facilities (15 million), home health and hospice care agencies (10 million), historically black colleges and universities, and tribal nation colleges.
House Democrats unveiled a new version of the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act – a $2.2 trillion COVID-19 relief package.
The AHA and Aligning for Health Sept. 24 hosted a webinar detailing how hospitals and health systems are working to better identify and address health, social and community needs.
Weekly COVID-19 cases among college-aged youth increased 55% nationally between Aug. 2 and Sept. 5, according to a report released by the Centers for Disease Control and Prevention.
AHA’s The Value Initiative is providing new resources to support hospitals’ and health systems’ efforts to adopt team-based care for patients with an acute or chronic illness.
A Lancet study published Sept. 25 indicates that few in the U.S. adult population formed antibodies against SARS-CoV-2, at least during the virus’ first wave in this country.
The Centers for Medicare & Medicaid Services released a guide to help laboratories apply for Clinical Laboratory Improvement Amendments certification, which includes information on the expedited review process implemented for the COVID-19 public health emergency.
States and COVID-19 testing laboratories have reported more than 277,000 COVID-19 cases in school-aged children since March, with about twice as many cases in children aged 12-17 than younger children, the Centers for Disease Control and Prevention reported.
The COVID-19 pandemic has brought increased attention to the issue of health care disparities. And it’s clear we’ve got a lot of work ahead of us to close the gaps.
The AHA urged the Department of Health and Human Services to reinstate the COVID-19 Provider Relief Fund reporting requirements outlined in its June 19 FAQ that defined both expenses and lost revenues attributable to COVID-19.
More than 200,000 of our friends, family members, fellow citizens and front-line workers have succumbed to COVID-19 since March. To put that in context, that’s approximately the same as the population of Salt Lake City, Utah.
Two clinical trials launched in April to evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19 are expanding, the National Institutes of Health announced.
The Centers for Medicare & Medicaid Services announced $165 million in supplemental funding to help 33 states participating in the Money Follows the Person Medicaid demonstration transition older adults and individuals with disabilities from long-term care facilities to home and community-based settings, including in response to the COVID-19 pandemic.
The Centers for Disease Control and Prevention awarded $200 million in Coronavirus Aid, Relief, and Economic Security Act funds to help states, territories and other jurisdictions prepare to distribute and administer COVID-19 vaccine.
Johnson & Johnson said that its COVID-19 vaccine candidate is moving to a global phase 3 clinical trial.
Nearly 30 representatives urged House leaders to modify in the next COVID-19 response package impending thresholds for qualifying participants in Advanced Alternative Payment Models, which they said threaten to “derail” the movement to value-based care under the Medicare Access and CHIP Reauthorization Act.